However, under pathophysiological conditions, FGF23 production in other organs may be ramped up, including kidney in polycystic kidney disease [38], heart in cardiac pathologies [13, 39], or bone marrow in iron deficiency anemia [40]. Here, FGF23 is linked to polycystic kidney disease.